NCT04416490View on ClinicalTrials.gov

Oxaliplatin Adjuvant Chemotherapy After Curative Resection of Primary Colon Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

2,013

Participants

Timeline

Start Date

March 25, 2020

Primary Completion Date

February 28, 2027

Study Completion Date

February 28, 2027

Conditions
Stage II Colon CancerStage III Colon Cancer
Trial Locations (1)

Unknown

Yonsei University Health System, Severance Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY

NCT04416490 - Oxaliplatin Adjuvant Chemotherapy After Curative Resection of Primary Colon Cancer | Biotech Hunter | Biotech Hunter